CML Therapy: A Focus on Second- and Third-Generation Tyrosine Kinase Inhibitors

Alexandra Lovell, Elias Jabbour, Jorge Cortes, Hagop Kantarjian

Research output: Chapter in Book/Report/Conference proceedingChapter

Fingerprint

Dive into the research topics of 'CML Therapy: A Focus on Second- and Third-Generation Tyrosine Kinase Inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences